GH: UNH Updates Medical Policy to Include Shield Blood Based CRC Screening for Commercial and Exchange Plans

Research evidence excerpt

GH: UNH Updates Medical Policy to Include Shield Blood Based CRC Screening for Commercial and Exchange Plans

ecurities Research Services, LLC (an investment adviser, “GSRS,”

and together with Guggenheim Securities, “Guggenheim”). If you are paying separately for this research, it is being provided to you by GSRS. Otherwise, it

is being provided by Guggenheim Securities. Guggenheim does not create tailored or personalized research and all research provided by Guggenheim is

impersonal advice. Other than disclosures relating to Guggenheim and our affiliates, this research is based on current public information that we consider

reliable, but we do not represent it is accurate or complete, and it should not be relied on as such.

This report is being distributed solely for the recipient’s internal use and may not be copied, reproduced, or distributed, in whole or in part, without the

prior written consent of Guggenheim. Without limiting the foregoing, the recipient is expressly prohibited from uploading, feeding, transmitting, or otherwise

providing this report or any related content to any internal or third-party artificial intelligence (“AI”) or machine learning system, including but not limited to

generative AI platforms, large language models, or similar technologies, without the prior written consent of Guggenheim.

Portions of the research contained herein have been generated using artificial intelligence ("AI"). We primarily use AI to gather general market or industry

data and to compile company-specific information to facilitate the recipient's preliminary review. In providing this research, we assume that any information

obtained from public sources, data suppliers (including AI systems) and other third parties is reasonable and reliable but acknowledge that any such